For example, the downstream signaling pathways of epidermal growth factor receptor (EGFR), such as Akt or ERK, were aberrantly activated, promoting tumor cell proliferation and leading to EGFR-TKI afatinib resistance in head and neck squamous cell carcinoma (12). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.